• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nitroso-redox balance in the cardiovascular system.

作者信息

Hare Joshua M

出版信息

N Engl J Med. 2004 Nov 11;351(20):2112-4. doi: 10.1056/NEJMe048269. Epub 2004 Nov 8.

DOI:10.1056/NEJMe048269
PMID:15533853
Abstract
摘要

相似文献

1
Nitroso-redox balance in the cardiovascular system.心血管系统中的亚硝基氧化还原平衡
N Engl J Med. 2004 Nov 11;351(20):2112-4. doi: 10.1056/NEJMe048269. Epub 2004 Nov 8.
2
Race-based therapeutics.基于种族的疗法。
N Engl J Med. 2004 Nov 11;351(20):2035-7. doi: 10.1056/NEJMp048271. Epub 2004 Nov 8.
3
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.硝酸异山梨酯与肼苯哒嗪联合用于黑人心力衰竭患者
N Engl J Med. 2004 Nov 11;351(20):2049-57. doi: 10.1056/NEJMoa042934. Epub 2004 Nov 8.
4
Color blind, or just plain blind?
Altern Med Rev. 2005 Jun;10(2):81-2.
5
Drug success signals a new trend. A "race-based" medication is a step toward individualized care.
Heart Advis. 2005 Apr;8(4):4-5.
6
Race and a heart drug.
Minn Med. 2005 Mar;88(3):11.
7
Introduction: Facts and fictions: BiDil and the resurgence of racial medicine.
J Law Med Ethics. 2008 Fall;36(3):443-8. doi: 10.1111/j.1748-720X.2008.289.x.
8
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.硝酸异山梨酯-肼屈嗪联合治疗非裔美国人心力衰竭
Vasc Health Risk Manag. 2006;2(4):423-31. doi: 10.2147/vhrm.2006.2.4.423.
9
BiDil for heart failure.
Med Lett Drugs Ther. 2005 Sep 26;47(1218):77-8.
10
Isosorbide dinitrate and hydralazine in blacks with heart failure.
N Engl J Med. 2005 Mar 10;352(10):1041-3; author reply 1041-3.

引用本文的文献

1
Growth hormone-releasing hormone signaling and manifestations within the cardiovascular system.生长激素释放激素信号传导及其在心血管系统中的表现
Rev Endocr Metab Disord. 2025 Jan 30. doi: 10.1007/s11154-024-09939-0.
2
The Microenvironment of the Pathogenesis of Cardiac Hypertrophy.心肌肥厚发病机制的微环境。
Cells. 2023 Jul 4;12(13):1780. doi: 10.3390/cells12131780.
3
Biodegradable magnesium materials regulate ROS-RNS balance in pro-inflammatory macrophage environment.可生物降解镁材料在促炎巨噬细胞环境中调节ROS-RNS平衡。
Bioact Mater. 2022 Nov 17;23:261-273. doi: 10.1016/j.bioactmat.2022.10.017. eCollection 2023 May.
4
S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer.CSF1 受体的 S-亚硝基化增加了 CSF1R 阻断对前列腺癌的疗效。
Cell Death Dis. 2022 Oct 8;13(10):859. doi: 10.1038/s41419-022-05289-4.
5
Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies.活性氧诱导的心力衰竭发病机制途径及潜在治疗策略
Biomedicines. 2022 Mar 3;10(3):602. doi: 10.3390/biomedicines10030602.
6
Similarities and Differences Between HFmrEF and HFpEF.射血分数保留的心力衰竭（HFpEF）与射血分数中间值的心力衰竭（HFmrEF）之间的异同
Front Cardiovasc Med. 2021 Sep 20;8:678614. doi: 10.3389/fcvm.2021.678614. eCollection 2021.
7
Reactive Oxygen Species and Endothelial Ca Signaling: Brothers in Arms or Partners in Crime?活性氧与内皮细胞钙信号传导：战友还是共犯？
Int J Mol Sci. 2021 Sep 10;22(18):9821. doi: 10.3390/ijms22189821.
8
Myocardial Disease and Long-Distance Space Travel: Solving the Radiation Problem.心肌病与长途太空旅行：解决辐射问题
Front Cardiovasc Med. 2021 Feb 12;8:631985. doi: 10.3389/fcvm.2021.631985. eCollection 2021.
9
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics.一氧化氮在癌症及抗癌治疗中的最新进展
Vaccines (Basel). 2021 Jan 27;9(2):94. doi: 10.3390/vaccines9020094.
10
Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction.生长激素释放激素激动剂可改善伴有射血分数保留的慢性肾脏病性心力衰竭。
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4). doi: 10.1073/pnas.2019835118.